Traumatic brain injury (TBI) is a major public health issue, with recently increased awareness of the potential longterm sequelae of repetitive injury. Although TBI is common, objective diagnostic tools with sound neurobiological predictors of outcome are lacking. Indeed, such tools could help to identify those at risk for more severe outcomes after repetitive injury and improve understanding of biological underpinnings to provide important mechanistic insights. We tested the hypothesis that acute and subacute pathological injury, including the microgliosis that results from repeated mild closed head injury (rmCHI), is reflected in susceptibility-weighted magnetic resonance imaging and diffusion-tensor imaging microstructural abnormalities. Using a combination of high-resolution magnetic resonance imaging, stereology, and quantitative PCR, we studied the pathophysiology of male mice that sustained seven consecutive mild traumatic brain injuries over 9 days in acute (24 hr) and subacute (1 week) time periods. rmCHI induced focal cortical microhemorrhages and impaired axial diffusivity at 1 week postinjury. These microstructural abnormalities were associated with a significant increase in microglia. Notably, microgliosis was accompanied by a change in inflammatory microenvironment defined by robust spatiotemporal alterations in tumor necrosis factor-a receptor mRNA. Together these data contribute novel insight into the fundamental biological processes associated with repeated mild brain injury concomitant with subacute imaging abnormalities in a clinically relevant animal model of repeated mild TBI. These findings suggest new diagnostic techniques that can be used as biomarkers to guide the use of future protective or reparative interventions. V C 2016 Wiley Periodicals, Inc.
Every year in the United States, approximately 2.5 million people seek emergency medical treatment for a traumatic brain injury (TBI; Faul and Coronado, 2015) . Although TBI is a growing major public health issue (Marin et al., 2014) , diagnostic tools and readily available neurobiological predictors of outcomes for TBI are lacking (Bruce et al., 2015) . The requirement for objective assessment criteria is amplified by the increasing concern over the consequences of repetitive trauma, especially if a second injury is sustained before complete recovery. Prior SIGNIFICANCE Understanding the pathophysiologic mechanisms of repetitive mild traumatic brain injury and the subsequent deficits is essential for accurate diagnosis, prognosis, and assessment of treatment. This preclinical investigation shows that repetitive mild closed head injuries induce focal cortical microhemorrhages and impair axial diffusion. These microstructural abnormalities are concomitant with significant increases in microglial load. Together, these data emphasize underpinnings of repeated mild brain injury that are consistent with subacute high-resolution diffusion tensor imaging and reveal multiple avenues for future mechanistic investigations. studies have suggested a temporal window of vulnerability after TBI, but without empirical measures of injury clinicians have limited tools to help guide critical management decisions seeking to prevent the sequelae of repetitive injury. Currently, computerized tomography scans and magnetic resonance imaging (MRI) with standard T1 and T2 sequences are the most frequently employed TBI diagnostic modalities, but the diagnostic and prognostic yield of these standard techniques is increasingly minor in the context of mild TBI. To stratify appropriate clinical resources and ensure the best treatment and followup care, objective diagnostic studies and biomarkers of injury must be identified and validated (Bruce et al., 2015) . This is especially vital in the case of mild TBI, in which clinical management is often based on subjective symptom reporting.
The first step to achieving objective diagnostic approaches is the development of appropriate preclinical models in which pathophysiological mechanisms are similar to those observed in humans and can be studied in depth. Previously, we have shown graded levels of neuropathology in mice subjected to repetitive mild closed head injury (rmCHI) as a result of varying the frequency, quantity, and severity of injuries, with more frequent injuries resulting in long-term cognitive deficits (Meehan et al., 2012; Mannix et al., 2013; Kondo et al., 2015) . Additionally, we demonstrated that mice subjected to rmCHI have impaired balance and spatial memory deficits that persist for 3 months after injury, concomitant with chronic astrocytosis and microgliosis .
Glial activation and upregulation of inflammatory mediators such as tumor necrosis factor-a (TNF-a) have been linked directly to the pathophysiology and progression of TBI (Webster et al., 2015) . Together with brain microstructure, regional and phenotypic glial activation data after repetitive mild TBI (rmTBI) may yield clinically relevant biomarkers and predictors of outcome. Furthermore, detailed analysis of complete sets of diffusion metrics (mean diffusivity [MD] , axial diffusivity [AD], radial diffusivity [RD] , and fractional anisotropy [FA] ) suggests that gliosis rather than cytotoxic edema is most consistent with changes in these parameters after acute mild TBI in humans (Croall et al., 2014) . Therefore, the present investigation uses a combination of high-resolution susceptibility-weighted magnetic resonance imaging (SWI) and diffusion tensor imaging (DTI) in tandem with a temporal and regional evaluation of microglia and common molecular mediators of a neuroinflammatory microenvironment. We test the hypothesis that rmCHI in mice leads to significant diffusion abnormalities concomitant with anomalous white and gray matter microstructure, microgliosis, and increased cytokine production in both the acute and the subacute phases postinjury.
MATERIALS AND METHODS
All experiments were approved by the institutional animal care and use committees at Boston Children's Hospital and the University of New Mexico and were conducted in compliance with the NIH Guide for the care and use of laboratory animals.
Experimental Design
Sample size estimates were developed a priori based on previous studies (Jantzie et al., 2014a; Mannix et al., 2014) . Pilot studies of DTI in rodents after controlled cortical impact (CCI) with the same imaging sequences, MRI scanner, and software analysis revealed that significant differences in FA, MD, AD, and RD were detected with a sample size of six or seven (Robinson et al., 2016) . A sample size of 10 was used for the DTI studies because we hypothesized that the effect size of microstructural changes after rmCHI would be smaller than that observed after CCI (Robinson et al., 2016) . We previously detected significant differences in stereological estimates of microgliosis with a sample size of three to five (Jantzie et al., 2014a; Mannix et al., 2014) . Here we used a sample size of six or seven for stereological estimates of microglial immunolabeling. For PCR analyses, a sample size of five to eight was used based on prior studies (Jantzie et al., 2014a) . Animals from at least two cohorts were used in all experiments.
rmCHI Two-month-old male wild-type C57BL/6 mice were randomized to undergo rmCHI or sham procedure, as previously described (Mannix et al., 2013 . Briefly, anesthesia was induced with 4% isoflurane in a 70:30 mixture of nitrogen and oxygen. Anesthesia exposure for each mouse was strictly controlled to 45 sec. Mice were placed on a delicate task wiper (Kimwipe; Kimberly-Clark, Irving, TX) and grasped by the tail. The head was placed directly under a hollow, 28-inch-tall guide tube. A 54-g metal bolt was used to deliver the impact to the dorsal aspect of the head. At impact, the mouse head readily penetrated the Kimwipe, documenting a rotational acceleration of the head. All mice recovered in room air. Injured mice underwent seven consecutive injuries over 9 days. Specifically, mice were injured daily for 5 days, followed by 2 days without injury, and then two additional daily injuries, consistent with previous reports . Sham mice underwent anesthesia only, at the same frequency and duration as injured animals.
MRI
One week after the seventh hit, mice were perfused with 4% paraformaldehyde (PFA). Brains were postfixed in 4% PFA for 1 week and embedded in 2% agarose containing 3 mM sodium azide for ex vivo MRI. Scanning was performed on a Bruker (Billerica, MA) 4.7-T BioSpec 47/40 ultrashielded refrigerated nuclear MRI system equipped with a quadrature RF coil (72-mm i.d.) and a small-bore (12-cm i.d.) gradient set with a maximum gradient strength of 50 Gauss/cm. MR protocols consisted of multislice multiecho spin echo and rapid acquisition with relaxation enhancement sequences for T2, echo planar DTI (EP-DTI), and SWI (SWI-FLASH). Images of 12 contiguous coronal 1-mm slices were obtained with a 2.00-cm field of view, 3,000-msec repetition time (TR), and 12-msec echo time (TE). EP-DTI sequences used a 3,000-msec TR, 40-msec TE, and 2,000 mm 2 /sec b-value with 30 diffusion gradient directions. SWI parameters were a 700-msec TR, 40-msec TE, and 408 flip angle with 10 averages, including a 256 3 256 acquisition matrix and a 30-min acquisition time. Brain regions of interest (ROIs), including major white matter tracts such as the corpus callosum, fimbria, and capsular white matter together with hippocampus and sensory cortex, were analyzed in Bruker's Paravision 5.1 imaging software. Tractography, diffusion-weighted images, SWIs, and FA maps were generated, and MD, AD (k 1 ), and RD ([k 2 1 k 3 ]/2) eigenvectors were calculated. Two observers blinded to treatment conditions evaluated animals from both treatment groups, with sham animals included in analysis to control for potential perfusion or fixation artifacts occasionally associated with SWI performed ex vivo. The numbers of microhemorrhages were counted through 12 contiguous coronal slices.
Prussian Blue Staining
A series of representative 6-lm coronal, paraffinembedded brain sections (average of seven sections per mouse) encompassing the anterior to posterior regions of the cortex, including the level of the dorsal hippocampus, was cut on a vibratome. After deparaffinization, sections were washed and staining in freshly prepared aqueous hydrochloric acid/potassium ferrocyanide solution per standard protocols (S. Kallakuri et al., 2015) . Sections were then rinsed, counterstained, washed thoroughly to remove staining artifacts, dehydrated, cleared, and coverslipped with organic mounting media.
Immunohistochemistry
Serial 20-lm coronal brain sections were cut on a Leica (Nussloch, Germany) cryostat from the anterior frontal lobes through the posterior extent of the dorsal hippocampus with stereology protocols (Jantzie et al., 2014a; Mannix et al., 2014) . Sections were treated with 0.03% hydrogen peroxide; blocked with 10% normal goat serum and 0.1% Triton X-100 in phosphate-buffered saline (PBS); incubated with primary antibodies overnight at 48C; rinsed; incubated sequentially with appropriate biotinylated secondary antibodies (1:200; Vector, Burlingame, CA), Vectastain (Vector), and diaminobenzidine (DAB); and mounted with Permount. Primary antibody used for microglia was ionized calcium-binding adaptor molecule 1 (Iba1; 1:500; RRID:AB_2314667; Wako, Osaka, Japan), and primary antibody used for activated microglia/macrophages was cluster of differentiation 68 (CD68; 1:100; RRID:AB_323909; Serotec, Raleigh, NC; Table I ). For double labeling, Iba1 was stained as described above, followed by antibodies against CD206 (1:100; RRID:AB_2144905; Santa Cruz Biotechnology, Santa Cruz, CA) and species-appropriate fluorescent secondary antibodies (Table I) .
Stereological Estimates
All sections were coded prior to blinding, and the observer was blinded to injury group. A Leica microscope with a motorized stage and an electronic microcator was used with Stereologer software (Stereology Resource Center, St. Petersburg, FL) to perform the analyses. Object area fraction and volume probes were used to quantify the amount of Iba1-positive immunolabeling of microglia and CD68-positive immunolabeling of microglia/macrophages (n 5 6 or 7/group; Jantzie et al., 2014a) . Estimates of immunolabeling of each antigen were obtained with a thin section modification of the optical fractionator method (Gundersen et al., 1988; Mouton, 2014) . ROIs at 24 hr and 1 week after injury were defined in the hippocampus and the fimbria with anterior, posterior, medial, and lateral anatomical landmarks, and the amount of immunolabeling within each systematically spaced, unbiased sampling frame was estimated. Coefficients of error were calculated, and all were <0.10. At the completion of the stereological analyses, samples were decoded, and the mean and the SEM of the immunolabeling were calculated.
ELISA
Quantitative determination of mouse cortical and hippocampal TNF-a levels at 24 hr and 1 week postinjury (n 5 6-8/ group/time point) was performed with a Quantikine sandwich ELISA (R&D Systems, Minneapolis, MN) according to the manufacturer's specifications.
Quantitative PCR
Hippocampus and cortex from mice at 24 hr and 1 week postinjury (n 5 5-8/group/time point) were rapidly dissected for RNA isolation (RNeasy Mini kit; Qiagen, Germantown, MD). Genes that were investigated represented pro-and antiinflammatory ligands and receptors, including CD86, inducible nitric oxide synthase (iNOS), CD206, TNF-a, interleukin (IL)-1b, IL-1bR, TNFR1, and TNFR2. Primer sequences were verified with the National Center for Biotechnology Information nucleotide basic local alignment search tool and are listed in Table II . Gene-of-interest primers and cDNA synthesized from 0.9 lg RNA were added to Power Sybr Green MasterMix (Life Technologies, Grand Island, NY) or Taqman probes (Invitrogen, Grand Island, NY) and run in triplicate on (Jantzie et al., 2014a,b) . Experimental replicates that varied by more than 0.25 Ct values were excluded from all experiments.
Statistical Analysis
Observers blinded to injury status performed quantification of MRI and immunolabeling. Differences between two groups were compared with Student's t-test or Mann Whitney U-test, and differences among more than two groups were compared with two-way ANOVA with Bonferroni correction. Data are mean 6 SEM. P < 0.05 was considered significant.
RESULTS rmCHI Induces Focal Cortical Microhemorrhage and Impairs Axial Diffusion
No animal had prolonged (>90 sec) loss of consciousness or any seizure activity after CHI. No focal lesions on standard T2-weighted images were observed for any animal (data not shown). Accordingly, because SWI exploits the distinct magnetic susceptibility effects of extracellular and extravascular blood products in the brain, we used a susceptibility-weighted sequence to evaluate miniscule hemorrhages. Microhemorrhages were defined a priori as foci with increased SWI signal not associated with bone, vessel, or MRI artifact, in line with clinical literature (Goos et al., 2011; J. Liu et al., 2014; Mori et al., 2014; S. Liu et al., 2016) . For injured animals, the median number of focal hypointensitites was three, and as expected there were significantly more throughout the brain but diffusely primarily throughout the cortical mantle in rmCHI animals compared with sham animals (median sham animals 5 0, n 5 6; P 5 0.045, Mann Whitney U-test; Fig. 1 ). Presence of microhemorrhage was confirmed histologically by evaluating Prussian blue-stained sections (Fig. 1) . Compared with sham animals (Fig. 1C) , which had no Prussian blue reaction products, rmCHI animals had focal microhemorrhages identified by blue deposits throughout the neuropil, consistent with previous reports (Kallakuri et al., 2015) . Prussian blue streaks were observed diffusely primarily throughout the cortex, with additional presence detected in the subcortical structures of the hippocampus and the thalamus. These SWI and histological data are consistent with diffuse microhemorrhage detected throughout the brain 1 week after rmCHI.
To investigate microstructural abnormalities in detail, we performed a thorough ex vivo multiregional, multidirectional DTI analysis including FA, MD, AD, and RD in the corpus callosum, fimbria, sensory cortex, and hippocampus at 1 week post-rmCHI (Figs. 2 and 3), Table III ). Despite finding that there were no significant differences in MD in either the corpus callosum or the fimbria, a reduced AD (k 1 ) was observed in the white matter 1 week after rmCHI (Fig. 2) . Specifically, rmCHI animals had reduced AD at 1 week in the corpus callosum compared with sham animals (all n 5 10; P 5 0.03, twotailed Student's t-test; Fig. 3) . Similarly, AD was lower in the fimbria (n 5 10; P 5 0.04, two-tailed Student's t-test) and in the capsular white matter (n 5 10; P 5 0.03, two tailed Student's t-test) after rmCHI, suggesting that the injury to the white matter was widespread (Fig. 3) . No change in AD was apparent in the gray matter structures of the sensory cortex and hippocampus (Table III) . Additionally, no differences in FA or RD were noted in any brain regions examined (Table III) . Together these data suggest significantly abnormal diffusion parallel to axons after rmCHI and are consistent with subacute white matter microstructural abnormalities.
rmCHI Induces Acute and Subacute Regional Microgliosis
To determine whether a microglial reaction occurred along with the microstructural changes on DTI, we estimated the amount of Iba1-immunolabeled microglia and CD68-immunolabeled microglia/macrophages using stereology at 24 hr and 1 week postinjury in both white and gray matter (Fig. 4) . Twenty-four hours after the final hit, Iba1-positive immunolabeling increased 1.7-fold in fimbria white matter (n 5 6 or 7; P < 0.01, two-way ANOVA; Fig. 4B ). This increase was maintained 1 week postinjury (n 5 6 or 7; P < 0.01, two-way ANOVA; Fig. 4B ). The Iba1-positive immunolabeling was accompanied by parallel increases in CD68-positive activated microglia/macrophages at both time points (n 5 6 or 7; both P < 0.001, two-way ANOVA; Fig. 4C ). These results show that rmCHI causes an early white matter microgliosis that is sustained into the subacute period. TCA ACA AGA GC  TGT CCT CAT CCT GGA AGG TCC ACG  IL-1bR  ACC CCC ATA TCA GCG GAC CG  TTG CTT CCC CCG GAA CGT AT  TNF-a  CGG GGT GAT CGG TCC CCA AAG  GGA GGG CGT TGG CGC GCT GG  TNFR1  CTC AGG TAC TGC GGT GCT GTT  TCG GCA CAT TAA ACT GAT GAA GAT  TNFR2  GGA ACC TGG GTA CGA GTG CCA  GCG GAT CTC CAC CTG GTC AGT  iNOS  CCC TTC AAT GGT TGG TAC ATG  ACA TTG ATC TCC GTG ACA GCC  CD86  GAG CGG GAT AGT AAC GCT GA  GGC TCT CAC TGC CTT CAC TC  CD206 CTT CGG GCC TTT GGA ATA AT TAG AAG AGC CCT TGG GTT GA
Similarly to the pattern observed in the white matter, more immunolabeled microglia were present in gray matter at both 24 hr and 1 week after rmCHI (Fig. 4D) . Regional analysis revealed that the baseline population of Iba1-immunolabeled microglia was approximately fourfold greater in the hippocampal CA1 subfield compared with the nearby fimbria. Similarly to the severity and time course of microgliosis noted after injury in the white matter, Iba1 immunolabeling in rmCHI CA1 was elevated 1.6-fold compared with sham animals at both 24 hr and 1 week (two-way ANOVA, both P < 0.001; Fig. 4E ). Changes in CA1 subfield CD68 immunolabeling mirrored the increases in Iba1-postive labeling at both 24 hr and 1 week (two-way ANOVA, both P < 0.001; Fig.  4F ), consistent with increased microglial/macrophage activation after rmCHI. Thus, rmCHI induces sustained microgliosis in both gray and white matter that persists into the subacute period.
Inflammatory Microenvironment Changes Occur After rmCHI
Given that the microgliosis after rmCHI suggested a robust inflammatory phenotype and that inflammation is known to promote secondary injury after TBI (Hinson et al., 2015) , we investigated molecules implicated in immune cell polarity, putative inflammatory signal transduction, and inflammatory microenvironment at discrete time points after injury. First, we assessed mRNA levels of CD86, iNOS, IL-1b, and CD206, genes that represent the extremes of classical proinflammatory and antiinflammatory immune cell polarity/microenvironment . No changes in CD86, iNOS, or IL1bR mRNA levels were detected in either cortex or hippocampus at both the 24 hr and the 1 week time points (data not shown). However, CD206 mRNA was increased in the cortex of rmCHI animals at 24 hr (n 5 5-8; P 5 0.03, two-tailed Student's t-test; Fig. 5A ) and observed on Iba1-positive microglia after rmCHI (Fig.  5B) . No difference in CD206 levels was present at 1 week (data not shown).
To expand our assessment of putative inflammatory mediators further, we complimented the abovementioned qPCR data by assessing regional changes in TNF-a after rmCHI via ELISA and qPCR at 24 hr and 1 week after injury (Fig. 6) . We found no statistically significant changes in TNF-a protein levels in either region at either time (Fig. 6A,B,E,F) . Given that cytokine signaling is highly dependent on function of cognate receptors and ultimately determines the nature of signal transduction, we measured TNFR mRNA to begin to understand the temporal nature of TNFR expression (Erickson and Banks, 2011) . Alterations in TNF-a inflammatory signaling pathway mRNA were detected in the cortex and the hippocampus after rmCHI. Specifically in the cortex at 24 hr after injury, no changes in cortical TNFR1 or TNFR2 mRNA were observed (data not shown). One week after injury, however, both cortical TNFR1 and TNFR2 mRNA levels were reduced in rmCHI cortex compared with shams (two-tailed Student's t-test, both P < 0.001; Fig. 6C,D) , consistent with altered cortical TNF-a signal transduction 1 week after injury (Naude et al., 2011) . However, a different pattern of changes in TNFR mRNA was observed in the hippocampus. No differences in hippocampal TNFR1 mRNA levels were observed at either 24 hr or 1 week (data not shown), but TNFR2 mRNA levels were increased in rmCHI hippocampi at 24 hr compared with sham (two-tailed Student's t-test, P 5 0.03; Fig. 6G ). At 1 week, this TNFR2 pattern was reversed and became similar to that of the cortex, with the hippocampus showing reduced TNFR2 mRNA levels after rmCHI compared with sham (two-tailed Student's t-test, P 5 0.004; Fig. 6H ).
DISCUSSION
TBI is a critical public health issue affecting over 2.5 million people worldwide (Budde et al., 2011; Cox et al., 2011) . Recovery is often patient specific and can be limited, given the lack of effective treatment strategies (Budde et al., 2011) . With these clinical issues in mind, we developed a mouse model to study the functional outcome and pathophysiology of rmTBI (Mannix et al., 2013 . Previously, we reported that seven hits over 9 days, as performed in the present study, results in loss of consciousness on days 1 and 2, concomitant with acute, Fig. 2 . Diffusion maps illustrate the directionality of diffusion with colors: red, transverse; green, vertical; blue, orthogonal to the plane. After rmCHI, subtle loss of color and directionality is evident in multiple regions, including white matter, consistent with microstructural injury and abnormal diffusion. Manual drawings of ROIs on representative T2 image in the coronal view demarcating the corpus callosum (yellow), capsular white matter (orange), fimbria (red), hippocampus (blue), and sensory cortex (green). [Color figure can be viewed at wileyonlinelibrary.com] Fig. 3 . MD quantifies the mean of the three eigenvectors, and AD quantifies changes in the primary eigenvector. A: One week after rmCHI, no change in MD is present in white matter corpus callosum. B: Significant reduction of AD is observed 1 week after rmCHI in white matter corpus callosum. C: No change in fimbria MD is evident 1 week after rmCHI. D: Reduced AD is also present in the fimbria 1 week after rmCHI. E: Consistent with the other white matter regions, MD is unchanged in the capsular white matter after rmCHI. F: AD is significantly reduced in capsular white matter 1 week after rmCHI (n 5 10; *P < 0.05, Student's two-tailed t-test).
subacute, and chronic deficits in spatial memory as well as hyperactivity and compromised motor performance (Mannix et al., 2013 . Collectively these data offer a behavioral phenotype that has correlates in the clinical entity of concussion and provide a translational platform for mechanistic studies. Having established that this model produces a sustained functional deficit, we extend these investigations here by demonstrating that rmCHI yields subacute cortical microhemorrhage and reduced AD at 1 week together with increased microgliosis and regional and temporal dysregulation of TNFR1 and TNFR2 gene expression.
Sensitive imaging techniques have been used increasingly both experimentally and clinically to assess TBI. These techniques incorporate multimodal MRI information on network functionality, microstructural integrity, tissue perfusion, hemorrhage and iron deposition, inflammation, edema, and regional volume loss (Benson et al., 2012; Mannix et al., 2013; Kallakuri et al., 2015) . In line with this concept, we performed a sophisticated multimodal MRI investigation in mice 1 week post-rmTBI using DTI and SWI. We assessed FA, MD, AD, and RD in mice to examine specific direction-and orientation-dependent variation in water diffusivity (Mukherjee et al., 2001; Mukherjee and McKinstry, 2006; Owen et al., 2013) . We found significantly decreased AD in multiple regions, including the corpus callosum, fimbria, and capsular white matter, consistent with impaired diffusion parallel to axons and microstructural aberrations. Indeed, the mechanical forces of rmTBI may result in stretching and disruption of subcellular and extracellular compartments, resulting in the dysregulated diffusion observed here (Povlishock and Katz, 2005; Browne et al., 2011; Mayer et al., 2012) . Previously, we reported that H&E-and SMI31-immunostained sections failed to reveal significant numbers of spheroids in major white matter tracts in injured mice 6 months after rmCHI (Mannix et al., 2013) . However, the MRI analysis of white matter diffusivity encompassing directional diffusion measures, including AD and RD, performed here provides thorough microstructural information on axonal status in the subacute phase (Mukherjee et al., 2001; Mukherjee and McKinstry, 2006; Mac Donald et al., 2007; Fox et al., 2008; Budde et al., 2009; Owen et al., 2013) . Indeed, neurofilaments can be damaged without physical beading, with altered transport processes along the axon and at the cellular level. Typically, this injury manifests as increased membrane permeability, resulting in a decrease in the diffusion metric parallel to axonal plane (AD) as shown here (Mac Donald et al., 2007) . Our data are in line with and supportive of compelling clinical literature that includes athletes and patients with poor neuropsychological outcome who show similar AD changes in the corpus callosum and subcortical white matter (Mac Donald et al., 2007; Kumar et al., 2009; Benson et al., 2012; Pasternak et al., 2014; Lancaster et al., 2016) .
The utility of multimodal MRI after rmTBI is best supported by its sensitivity to multiple pathophysiological processes and markers missed by conventional MRI, without requiring neuropathological assessment. For example, SWI exploits the magnetic susceptibility differences in blood, iron, and calcium. Here, we report diffuse cortical microhemorrhages on SWI 1 week post-rmCHI, confirmed histopathologically with positive Prussian blue reaction products in the cortical neuropil of injured animals. Clinically, the number, localization, type, and magnitude of microhemorrhage are associated with severity of injury and prognostication of functional outcome at 6-12 months (L. S. Liu et al., 2016; Toth et al., 2016) . The number and extent of microbleeds is dynamic, however (Toth et al., 2016) , emphasizing the importance of longitudinal and noninvasive SWI assessment of hemorrhage concomitant with clinical signs. Prussian blue detects hemosiderin deposits at a cellular level in sections 4-6-lm thin, allowing for much greater resolution of reactive blood products. However, direct numerical comparisons between pathological and neuroradiological microbleeds must be made cautiously because it is difficult to compare Prussian blue reaction products as observed under the microscope directly with the paramagnetic product of heme degradation resulting in homogenous signal loss on MRI (Greenberg et al., 2009; Toth et al., 2016) . Indeed, bleeds are often smaller and more numerous than they appear on SWI (Greenberg et al., 2009; Kallakuri et al., 2015; J. Liu et al., 2014; S. Liu et al., 2014 S. Liu et al., , 2016 Toth et al., 2016) .
Undoubtedly, the cellular composition of and contribution to diffusivity is multifaceted, and the contribution of glia to pathophysiological processes after TBI cannot be underestimated (Budde et al., 2011) . Neuroinflammation, including microglia and macrophage proliferation, is a robust response to TBI and likely plays a role in changes in diffusivity seen in both humans and animals after injury (Budde et al., 2011) . Thus, we investigated microglia in the first week after rmCHI, temporally consistent with our imaging investigations. Here, we show significant increases in Iba1 and CD68 immunolabeling in major white and gray matter structures after rmCHI beginning 24 hr after injury and persisting through the first week post-injury. These data are in line with our prior data showing microgliosis and astrocytosis 3 months after rmCHI (Mannix et al., 2013 .
Just as in the peripheral immune system, CNS microglia and macrophages are highly plastic and assume diverse phenotypes in response to specific changes in the local microenvironment. Indeed, several genes are associated with different microglial activation states and diseasespecific molecular inflammatory signatures (Chiu et al., 2013; Hickman et al., 2013; Butovsky et al., 2014) . Therefore, after establishing increases in gray and white matter microglial load with corresponding increases in activation state (increased CD68 immunoreactivity), we performed qPCR in discrete brain regions for genes classically associated with proinflammatory states (iNOS, CD86, TNF-a, and IL-1b) and anti-inflammatory microenvironments (CD206, TNFR2). We consistently observed changes in TNFR gene expression in the absence of overt injury-induced alterations in TNF-a protein itself, defined by significant decreases in both TNFR1 and TNFR2 mRNA expression in the cortex 1 week after injury. Additionally, we observed upregulated TNFR2 mRNA in the hippocampus of rmCHI mice at 24 hr, which was subsequently downregulated after 1 week. Cytokine signaling is highly dependent on the function of cognate receptors, mRNA expression, receptor cross-talk signaling kinetics, and pro-and antiinflammatory signals in the microenvironment (Opal and DePalo, 2000; Erickson and Banks, 2011; Naude et al., 2011) . Thus, measuring numerous cytokines together with their receptors provides a snapshot of their influence on physiology and captures the temporal nature of their expression (Erickson and Banks, 2011) . TNF-a is one of the prominent mediators after TBI, driving the activation, proliferation, and hypertrophy of mononuclear and phagocytic cells, including microglia and astrocytes. Other investigators have shown that increased TNF-a signaling through TNFR1 exacerbates functional deficits after TBI (Longhi et al., 2013) , whereas signaling through TNFR2 is neuroprotective (Yang et al., 2010) . Indeed, TNFR2 deletion impairs novel object recognition, spatial memory recognition, contextual fear conditioning, and motor performance and can increase anxiety-like behavior in young adult mice (Naude et al., 2014) , a behavioral phenotype in line with our findings in this model of rmCHI. We also found CD206 mRNA, a molecule previously documented to be central to microglial response after TBI , to be acutely increased in the cortex after rmCHI. Together with increased Iba1 and CD68 immunolabeling, our results indicate that Fig. 4 . Immunolabeling of Iba1-positive microglia reveals microgliosis after rmCHI. A: More Iba1-positive immunolabeling of microglia is present in the fimbria 1 week after rmCHI. B: Stereological estimates of Iba1-positive immunolabeling reveal that more microglial labeling is present in the fimbria at both early and subacute intervals after rmCHI. C: CD68-positive activated microglia/macrophage immunolabeling is more prevalent in the fimbria at both acute and subacute intervals after rmCHI. D: In the hippocampal CA1 subfield, more Iba1-positive immunolabeling is present 1 week after rmCHI. E: Stereological estimates confirm that markedly more Iba1-positive immunolabeled microglia are present in the CA1 1 week after rmCHI. F: More CD68-immunolabeled activated microglia/macrophages are present in CA1 1 week after the rmCHI. N 5 6 or 7; *P < 0.05, **P < 0.01, ***P 0.001, two-way ANOVA. Scale bars 5 20 lm.
[Color figure can be viewed at wileyonlinelibrary.com] microglia/macrophages respond dynamically to rmCHI and likely influence overall pro-and anti-inflammatory signal transduction driven primarily through cytokine and chemokine receptors (i.e., TNFR1 and TNFR2) after rmTBI and may contribute to changes in diffusion, in line with prior reports (Budde et al., 2011) . . A: TNF-a protein expression is unchanged in the cortex 24 hr after rmCHI. B: Similarly, TNF-a levels are consistent across groups at 1 week. C: However, loss of TNFR1 mRNA occurs 1 week after rmCHI in the cortex. D: Similarly, cortical TNFR2 expression is also decreased 1 week after rmCHI. E,F: Consistent with the cortex, hippocampal TNF-a levels are unchanged at 24 hr (E) and 1 week (F) after rmCHI. G: However, TNFR2 mRNA expression is significantly increased in the hippocampus at 24 hr. H: This pattern reverses at 1 week, with TNFR2 mRNA expression significantly decreased, similarly to the cortex at this subacute interval. N 5 5-8; *P < 0.05, **P < 0.01, ***P 0.001, Student's two-tailed t-test.
A limitation of the current study is that MRI was performed ex vivo, so we are unable to provide in vivo evidence for the temporal relationship and the longitudinal evolution of diffusion changes and microhemorrhage in this model. Future studies that focus on uncovering the real-time evolution of diffusion metrics and structural coherence in this model are warranted through acute, subacute, and long-term recovery phases. Similarly, traumatic microbleeds are not static and change in number and extent. Thus, imaging at multiple time points after injury is important and relevant for optimizing the clinical prognostic utility of this biomarker and detecting the full burden of hemorrhagic and nonhemorrhagic diffuse axonal injury after repeated insult. Indeed, visibility of microbleeds on SWI is attenuated longitudinally because of hemosiderin absorption, a similar mechanism that has limited Prussian blue staining to detecting chronic hemorrhages via histology (J. S. Liu et al., 2014 S. Liu et al., , 2016 Toth et al., 2016) . Furthermore, rmCHI as described here produces loss of consciousness in the initial injury days, which is not common in sports-related concussions. Repetition of injury is a critical variable for preclinical modeling and assessment of the cumulative effect of rmTBI on cognitive function and molecular pathophysiology, and the importance of dose response to this end cannot be overemphasized given the diverse mechanisms and severity of human rmTBI. Finally, the qPCR data from cortical and hippocampal samples shown here represent expression on total CNS cells, including neurons and infiltrating immune cells, and are indicative of regional changes in mRNA in the cerebral microenvironment, not cell-specific changes in mRNA expression. Future studies in knockout mice (i.e., TNFR1 or TNFR2) and expanded longitudinal investigations of multiple cytokines in wild-type animals are required to provide conclusive evidence for the contribution of microglia and their polarization after rmCHI, including detailed analysis of protein expression and function.
In conclusion, rmCHI induced focal cortical microhemorrhages and impaired AD at 1 week postinjury and induced significant increases in Iba1-and CD68-positive microglia/macrophages throughout vulnerable gray and white matter regions. Notably, microgliosis was accompanied by a change in inflammatory microenvironment defined by robust spatiotemporal alterations in TNF-a receptor mRNA. Together, these data contribute relevant neuropathological substrates of repeated mild brain injury and support new diagnostic techniques that can be used as biomarkers to guide the use of future protective or reparative interventions.
